Status:
COMPLETED
Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Bristol-Myers Squibb
Conditions:
Venous Thromboembolic Disease
Kidney Failure, Chronic
Eligibility:
All Genders
18+ years
Brief Summary
Patients with end stage renal disease (ESRD) are at significantly increased risk of thrombosis and bleeding relative to those with normal renal function which makes anticoagulation particularly challe...
Detailed Description
The investigators will perform a retrospective cohort analysis using USRDS data from 2014 through 2018 and a descriptive serial cross-sectional analysis using USRDS data from 2009 through 2018 to eval...
Eligibility Criteria
Inclusion
- ESRD on dialysis with acute VTE
Exclusion
- Anticoagulation for non-VTE indication
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
14914 Patients enrolled
Trial Details
Trial ID
NCT04818151
Start Date
January 1 2021
End Date
June 30 2021
Last Update
July 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21287